Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) reached a new 52-week high during mid-day trading on Thursday. The stock traded as high as $103.22 and last traded at $102.82, with a volume of 3,115 shares trading hands. The stock had previously closed at $96.00.
Analysts Set New Price Targets
Separately, Erste Group Bank upgraded shares of Sandoz Group to a “strong-buy” rating in a research note on Thursday, August 27th. Four equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, Sandoz Group presently has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Analysis on SDZNY
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group AG is a Switzerland-based pharmaceutical company focused on generic and biosimilar medicines. Its portfolio includes prescription medicines across therapeutic areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular treatments. The company also supplies complex generics, including injectable, inhaled and other specialty formulations.
Sandoz serves patients and healthcare providers through a broad international commercial and manufacturing network, with operations and products spanning Europe, North America, Asia and other global markets.
Read More
- Five stocks we like better than Sandoz Group
- Plugging In: Vertiv Cashes In On AI Demand
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
- Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps Growing
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
